Skip to main navigation
Select the elements you want to hide on this page.
Save
Cancel
Finch Therapeutics logo
  • About
    Mission & Values Leadership Board of Directors Collaborators History Contact Us
  • Platform
    Human-First Discovery ® Platform IP Portfoilio Publications
  • Pipeline
    Overview Programs
  • Clinical Trials
  • Investors & News
    Overview Stock Information Press Releases Events & Presentations Publications Financials & Filings Corporate Governance Investor Resources Contact IR
  • Careers
    Overview Open Positions

SEC Filing Details

SEC Filing Details
  1. SEC Filings

SEC Filing Details

Document Details

Form
3
Filing Date
Sep 10, 2021
Document Date
Sep 8, 2021
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Finch Therapeutics
Issuer
Finch Therapeutics Group, Inc.
Filer
BLAUSTEIN MARC

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS
Print Page
Contact IR
RSS Feeds
E-mail Alerts

Contact us

info@finchtherapeutics.com 617-229-6499
200 Inner Belt Road,
Suite 400, Somerville, MA, 02143
Policies
© 2022 Finch Therapeutics Group, Inc. All rights reserved.